CMS Expands Medicare Coverage of MRI for Patients with FDA-Approved Pacemakers

ImagingEconomics | The Centers for Medicare & Medicaid Services (CMS) recently  expanded Medicare coverage of MRI for beneficiaries with implanted  pacemakers when used according to FDA-approved labeling in an MRI  environment. A final National Coverage Determination (NCD) provides  access to the MRI environment for patients with FDA-approved pacemakers.

On February 8, the FDA approved the RevoMRI SureScan Pacing System,  which is designed for use in the MRI environment for certain MRI exams.  Currently, there are no other pacemakers or implantable cardioverter  defibrillators that are FDA-approved for use in the MRI environment.

“This swift action by CMS provides patients who need a pacemaker with  greater access to MRI exams,” said Donald M. Berwick, MD, CMS  administrator. “The expedited review of this decision demonstrates our  commitment and support of new technology that will help improve the  health of our beneficiaries.”


No Comments

Sorry, the comment form is closed at this time.